Baxdrostat, Baxdrostat, Baxdrostat, Forxiga 10 mg film-coated tablets, Baxdrostat placebo
D6972C00002
Phase 3 small_molecule active
Quick answer
Baxdrostat, Baxdrostat, Baxdrostat, Forxiga 10 mg film-coated tablets, Baxdrostat placebo for Chronic kidney disease (CKD) and hypertension. is a Phase 3 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Chronic kidney disease (CKD) and hypertension.
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active